AMR Research
Showcasing the next generation of AMR researchers
PhD students and early career researchers showcase the latest advancements in antimicrobial research
Stories tagged with 'Antibiotics'
Tackling AMR
Meet the Imperial experts fighting bacterial resistance through innovation
Professor Shiranee Sriskandan and Dr Andrew Edwards shed light on the vital work of Imperial’s Centre for Bacterial Resistance Biology (CBRB).
Feature
Leading infection experts
Event summary: Clinician-scientist-engineer challenges workshop in infection
Leading infection experts came together to explore clinical challenges in infection and how Imperial’s interdisciplinary expertise can solve them.
Azithromycin
Life-saving drug for African children may drive antimicrobial resistance?
Editorial reviews azithromycin as a life-saving option for African children—but at the risk of increasing antimicrobial resistance.
Inaugural Director
Prof Alison Holmes appointed as inaugural Director of the Fleming Initiative
It was today announced that Professor Alison Holmes has been appointed as the inaugural Director of the Fleming Initiative.
Targeting AMR
Fleming Initiative raises first £100m in the global fight against AMR
As world leaders gather in New York to discuss the growing global health threat, the Fleming Initiative is poised to break down barriers to progress.
IGHI Summer School
IGHI launches the first Global Health Summer School for Year 13 Students
Last week, the Institute of Global Health Innovation (IGHI) hosted its first Global Health Summer School for 22 Year-13 students from London schools
Design Call
Search begins for architects to design new Fleming Centre
The Fleming Initiative is calling for designs for its inaugural Centre at St Mary’s Hospital.
NEW CBRB DIRECTORS
Imperial’s CBRB appoints new co-directors
Professor Mariagrazia Pizza and Professor Shiranee Sriskandan will lead the Centre for Bacterial Resistance Biology (CBRB).
Fighting AMR
GSK backs Imperial’s Fleming Initiative with £45m pledge to fight AMR
GSK will become the first partner of the new Imperial-led Fleming Initiative, which aims to tackle antimicrobial resistance globally.
